Global Biobanking Market Research and Forecast Report 2022-2027
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Biobanking Market Research Report: According to the latest report by IMARC Group, titled “ Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ,” the global biobanking market reached a strong growth in 2021. Biobanking refers to the process of storing and analyzing information regarding human biospecimens, which are accumulated from healthy volunteers with a particular condition. The collected information is further utilized in research and academic studies to enhance the understanding of health and numerous diseases. Modern biobanks indulge in the large-scale analysis of specific disease biomarkers, which include biological or digital materials with well-annotated clinical data. They offer a basis for enhancing personalized medical approaches where effective biomarker identification is crucial for diagnosis and prognosis. Request Free Sample Report: https://www.imarcgroup.com/biobanking-market/requestsample
Report Description and Highlights Report Description Global Biobanking Market Trends : The growing incidences of new infectious and chronic diseases and the escalating need for diagnostic procedures that accurately identify pathogens are primarily driving the biobanking market. Moreover, the increasing demand for regenerative medicines and personalized treatment options is further propelling the market growth. Besides this, several technological advancements in genomics, metagenomics, proteomics, disease biology, bioenergy, environmental remediation, and allied fields are acting as significant growthinducing factors. Furthermore, the expanding investments in virtual biobank network models by the health agencies across numerous countries are also augmenting the global market. In addition to this, various key market players are providing a diverse portfolio of biobanking products and services that allow the seamless sharing of insights and critical information between research establishments. This, in turn, is anticipated to fuel the biobanking market over the forecasted period. Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
Report Description and Highlights Report Description Market Summary: Breakup by Specimen Type: • Blood Products • Solid Tissue • Cell Lines • Nucleic Acid • Others Breakup by Biobank Type: • Population-based Biobanks • Disease-oriented Biobanks • Breakup by Application: • Therapeutics • Research • Breakup by End User: • Academic Institutions • Pharma and Biotech Companies
Report Description and Highlights Report Description Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others •Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others
Report Description and Highlights Report Description •Latin America • Brazil • Mexico • Others •Middle East and Africa Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • •
Brooks Automation Inc. Bay Biosciences LLC Boca Biolistics Ctibiotech Cureline Inc. Firalis Greiner Bio-One International GmbH Hamilton Company Merck KGaA ProteoGenex Inc. Thermo Fisher Scientific Inc. VWR Corporation (Avantor Inc.)
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/biobanking-market
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
We are the trusted business partners to the Partial Listworld's of Clients leading corporates, governments, and institutions
A partial List of our Clients
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com